Join Today & Get 4% Cash Back Then 6, 7...Up to 10% Off Reorders!

Online Pharmacy Dictionary

---

Find drugs by alphabetical list:
 A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  View All

---

News on Macugen (pegaptanib)

Eyetech announces program to develop extended-release anti-VEGF therapy - OSN SuperSite

OSN SuperSiteEyetech announces program to develop extended-release anti-VEGF therapyOSN SuperSiteUnder the agreement, the companies have launched the Macugen Microparticles Program to evaluate the feasibility of decreasing Macugen (pegaptanib sodium, ...Anti-VEGF therapy finds expanding role in ophthalmologyOSN SuperSiteall 2 news articles��

AAO: Anti-VEGF Drugs Making Leap to Diabetic Eye Disease - MedPage Today

AAO: Anti-VEGF Drugs Making Leap to Diabetic Eye DiseaseMedPage TodayRanibizumab (Lucentis) and pegaptanib (Macugen), both of which inhibit vascular endothelial growth factor (VEGF) signalling, were highly effective in ...

VEGF Blockers Seem Safe for Macular Degeneration - MedPage Today

MD News (press release)VEGF Blockers Seem Safe for Macular DegenerationMedPage Today... one year than those treated with photodynamic therapy or pegaptanib (Macugen) (hazard ratios 0.85 and 0.84, respectively), according to Lesley Curtis, ...Newer Therapies for Eye Disorder Not Tied to Heart ProblemsBusinessWeekAMD Treatments Don't Increase Risk of MortalityInternal Medicine News Digital Networkall 24 news articles��

Eyetech Announces Program to Develop Extended-Release Formulation of Macugen® - AUTO-MOBI.info (press release)

Eyetech Announces Program to Develop Extended-Release Formulation of Macugen®AUTO-MOBI.info (press release)Eyetech Inc. announced today a program to develop an extended-release formulation of Macugen ® (pegaptanib sodium injection) using microparticles technology ...and more��

Macugen (pegaptanib)

Last updated on: Jan 24, 2007

Brand Name:	Macugen
Active Ingredient:	pegaptanib sodium
Strength(s):	0.3 mg/90μL (1 mL vial)
Dosage Form(s):	Injection
Company Name:	Eyetech Pharmaceuticals Inc.; Pfizer, Inc.
Availability:	Prescription only
*Date Approved by FDA:	December 17, 2004
*Approval by FDA does not mean that the drug will be immediately marketed and  available for consumers at this time. This information is provided by the U.S. Food & Drug Administration. For more information about this drug, click here.

---

What is Macugen used for?

Macugen is used to treat adults with an eye problem called the wet form (neovascular) of age-related macular degeneration.  Macular degeneration causes vision loss leading to blindness.

Who should not be treated with Macugen? 

Do not use Macugen if you have an infection in or around your eye

Special Warning(s) with Macugen:  

Call your eye doctor right away if your eye becomes red, sensitivity to light, painful or you have changes in vision.  Macugen can cause a serious eye inflammation called endophthalmitis in the days following an injection.

General Precautions with Macugen:

• Your eye doctor should only inject one eye at a time with Macugen.

• Your eye doctor should monitor your eye for increased pressure and signs of infection right after each Macugen injection and during the week after each injection.

What should I tell my health care provider?

Tell your health care provider if you are pregnant, are trying to become pregnant, or are breast-feeding

What are some possible side effects of Macugen? (This list is NOT a complete list of side effects reported with Macugen.  Your health care provider can discuss with you a more complete list of side effects.) 

 The most common side effects with Macugen include:

• inflammation of the eye
• blurred vision or changes in vision
• cataracts
• bleeding in the eye
• swelling of the eye
• eye discharge
• irritation or discomfort of the eye
• eye pain
• seeing "spots" in your vision

©2010 eDrugSearch.com     Privacy Policy | Terms & Conditions | Sitemap | Advertising Program

Or search by name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

home about us pharmacies drugs safety community FAQ rewards blog contact us